BIO-TECHNE Corp Other Operating Activities, Cash Flow Statement
BIO-TECHNE Corp (TECH) reported Other Operating Activities, Cash Flow Statement of $477.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2026-08-24
- BIO-TECHNE Corp other operating activities, cash flow statement for the quarter ending 2026-06-30 was -$144.00K, a 116.02% decline year-over-year.
- BIO-TECHNE Corp other operating activities, cash flow statement for the quarter ending 2026-03-31 was -$42.00K, a 118.92% decline year-over-year.
- BIO-TECHNE Corp other operating activities, cash flow statement for the quarter ending 2025-12-31 was -$338.00K.
- BIO-TECHNE Corp other operating activities, cash flow statement for the quarter ending 2025-09-30 was $1.00M, a 7.06% increase year-over-year.
- BIO-TECHNE Corp other operating activities, cash flow statement for fiscal 2026 was $477.00K, a 66.55% decline from fiscal 2025.
- BIO-TECHNE Corp other operating activities, cash flow statement for fiscal 2025 was $1.43M, a 38.45% increase from fiscal 2024.
- BIO-TECHNE Corp other operating activities, cash flow statement for fiscal 2024 was $1.03M.
- BIO-TECHNE Corp other operating activities, cash flow statement for fiscal 2023 was -$17.00K, a 102.54% decline from fiscal 2022.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 3 month as first filed | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 6 month as first filed | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 9 month as first filed | Other Operating Activities, Cash Flow Statement 12 month | Other Operating Activities, Cash Flow Statement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$186.00K derived: sum of 2 quarters · filed 2026-08-24 | -$524.00K derived: sum of 3 quarters · filed 2026-08-24 | $477.00K 10-K · filed 2026-08-24 | ||||
| 2026-03-31 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$380.00K derived: sum of 2 quarters · filed 2026-05-06 | $621.00K 10-Q · filed 2026-05-06 | $1.52M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-12-31 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $663.00K 10-Q · filed 2026-02-04 | $1.56M derived: sum of 3 quarters · filed 2026-08-24 | $1.78M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-05 | $1.90M derived: sum of 2 quarters · filed 2026-08-24 | $2.12M derived: sum of 3 quarters · filed 2026-08-24 | $1.49M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-06-30 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $1.12M derived: sum of 2 quarters · filed 2026-08-24 | $491.00K derived: sum of 3 quarters · filed 2026-08-24 | $1.43M 10-K · filed 2026-08-24 | $675.00K 10-K · filed 2025-08-22 | |||
| 2025-03-31 | $222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$408.00K derived: sum of 2 quarters · filed 2026-05-06 | $527.00K 10-Q · filed 2026-05-06 | $1.14M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-12-31 | -$630.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $305.00K 10-Q · filed 2026-02-04 | $913.00K derived: sum of 3 quarters · filed 2026-08-24 | $1.08M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-09-30 | $935.00K 10-Q · filed 2025-11-05 | $747.00K 10-Q · filed 2024-11-05 | $1.54M derived: sum of 2 quarters · filed 2026-08-24 | $1.71M derived: sum of 3 quarters · filed 2026-08-24 | $1.78M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | $608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $774.00K derived: sum of 2 quarters · filed 2026-08-24 | $848.00K derived: sum of 3 quarters · filed 2026-08-24 | $1.03M 10-K · filed 2026-08-24 | $584.00K 10-K · filed 2024-08-22 | |||
| 2024-03-31 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $240.00K derived: sum of 2 quarters · filed 2025-05-08 | $422.00K 10-Q · filed 2025-05-08 | $109.00K derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-12-31 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $256.00K 10-Q · filed 2025-02-06 | -$57.00K derived: sum of 3 quarters · filed 2025-08-22 | $127.00K derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-09-30 | $182.00K 10-Q · filed 2024-11-05 | -$131.00K derived: sum of 2 quarters · filed 2025-08-22 | $53.00K derived: sum of 3 quarters · filed 2025-08-22 | $197.00K derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-06-30 | -$313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | -$129.00K derived: sum of 2 quarters · filed 2025-08-22 | $15.00K derived: sum of 3 quarters · filed 2025-08-22 | -$17.00K 10-K · filed 2025-08-22 | $455.00K 10-K · filed 2023-08-23 | |||
| 2023-03-31 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $328.00K derived: sum of 2 quarters · filed 2024-05-06 | $296.00K 10-Q · filed 2024-05-06 | $415.00K derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-12-31 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $112.00K 10-Q · filed 2024-02-07 | $231.00K derived: sum of 3 quarters · filed 2024-08-22 | $397.00K derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-09-30 | -$32.00K 10-Q · filed 2023-11-07 | $87.00K derived: sum of 2 quarters · filed 2024-08-22 | $253.00K derived: sum of 3 quarters · filed 2024-08-22 | $139.00K derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-06-30 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $285.00K derived: sum of 2 quarters · filed 2024-08-22 | $171.00K derived: sum of 3 quarters · filed 2024-08-22 | $668.00K 10-K · filed 2024-08-22 | ||||
| 2022-03-31 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $52.00K derived: sum of 2 quarters · filed 2023-05-08 | $549.00K 10-Q · filed 2023-05-08 | $693.00K derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-12-31 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $383.00K 10-Q · filed 2023-02-07 | $527.00K derived: sum of 3 quarters · filed 2023-08-23 | -$405.00K derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-09-30 | $497.00K 10-Q · filed 2022-11-07 | $641.00K derived: sum of 2 quarters · filed 2023-08-23 | -$291.00K derived: sum of 3 quarters · filed 2023-08-23 | -$162.00K derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-06-30 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$788.00K derived: sum of 2 quarters · filed 2023-08-23 | -$659.00K derived: sum of 3 quarters · filed 2023-08-23 | -$464.00K 10-K · filed 2023-08-23 | ||||
| 2021-03-31 | -$932.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | -$803.00K derived: sum of 2 quarters · filed 2022-05-09 | -$608.00K 10-Q · filed 2022-05-09 | -$475.00K derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-12-31 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $324.00K 10-Q · filed 2022-02-07 | $457.00K derived: sum of 3 quarters · filed 2022-08-24 | -$568.00K derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-09-30 | $195.00K 10-Q · filed 2021-11-08 | $195.00K 10-Q · filed 2020-11-09 | -$697.00K derived: sum of 3 quarters · filed 2022-08-24 | -$701.00K derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-06-30 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$892.00K derived: sum of 2 quarters · filed 2022-08-24 | -$896.00K derived: sum of 3 quarters · filed 2022-08-24 | -$732.00K 10-K · filed 2022-08-24 | ||||
| 2020-03-31 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | -$1.03M derived: sum of 2 quarters · filed 2021-05-07 | -$865.00K 10-Q · filed 2021-05-07 | -$674.00K 10-Q · filed 2020-05-11 | -$795.00K derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $160.00K 10-Q · filed 2021-02-08 | $192.00K 10-Q · filed 2020-02-06 | $230.00K derived: sum of 3 quarters · filed 2021-08-25 | $145.00K derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | $164.00K 10-Q · filed 2019-11-06 | $164.00K 10-Q · filed 2020-11-09 | $149.00K derived: sum of 3 quarters · filed 2021-08-25 | $272.00K derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-06-30 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$15.00K derived: sum of 2 quarters · filed 2021-08-25 | $108.00K derived: sum of 3 quarters · filed 2021-08-25 | $2.33M 10-K · filed 2021-08-25 | ||||
| 2019-03-31 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $38.00K derived: sum of 2 quarters · filed 2020-05-11 | $2.25M 10-Q · filed 2020-05-11 | $1.37M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-12-31 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $2.34M 10-Q · filed 2020-02-06 | $1.45M derived: sum of 3 quarters · filed 2020-08-26 | $1.56M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-09-30 | $2.22M 10-Q · filed 2019-11-06 | $1.33M derived: sum of 2 quarters · filed 2020-08-26 | $1.44M derived: sum of 3 quarters · filed 2020-08-26 | $2.72M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-06-30 | -$888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | -$780.00K derived: sum of 2 quarters · filed 2020-08-26 | $499.00K derived: sum of 3 quarters · filed 2020-08-26 | $776.00K 10-K · filed 2020-08-26 | ||||
| 2018-03-31 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $1.39M derived: sum of 2 quarters · filed 2019-05-07 | $1.66M 10-Q · filed 2019-05-07 | $4.79M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-12-31 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $1.56M 10-Q · filed 2019-02-07 | $4.68M derived: sum of 3 quarters · filed 2019-11-06 | $5.06M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-09-30 | $277.00K 10-Q · filed 2018-11-07 | $3.40M derived: sum of 2 quarters · filed 2019-11-06 | $277.00K 10-Q · filed 2017-11-09 | $3.74M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-06-30 | $3.13M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $3.50M derived: sum of 2 quarters · filed 2019-11-06 | $3.46M derived: sum of 3 quarters · filed 2019-11-06 | $2.21M 10-K/A · filed 2019-11-06 | ||||
| 2017-03-31 | $375.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $338.00K derived: sum of 2 quarters · filed 2018-05-09 | -$911.00K 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$1.29M 10-Q · filed 2018-02-08 | ||||||
| 2016-09-30 | -$1.25M 10-Q · filed 2017-11-09 | -$1.25M 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | -$279.00K 10-K · filed 2018-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |